[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Medicated Skin Care in Israel

February 2012 | 33 pages | ID: M15548F659BEN
Euromonitor International Ltd

US$ 990.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Medicated skin care exemplifies the recent slowdown of growth in consumer health due to strict regulations. Companies in Israel have recently realised the strong potential among the more profitable medical devices within medicated skin care products. There are many different products within medicated skin care. Lice treatment, for example, is highly influenced by sales of medical devices.

Euromonitor International's Medicated Skin Care in Israel report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Allergy Eye Care, Antihistamines/Allergy Remedies (Systemic), Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Diarrhoeal Remedies, First Aid Kits, Gauze, Tape and Other Wound Care, Haemorrhoid Treatments, Hair Loss Treatments, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Medicated Confectionery, Medicated Shampoos, Motion Sickness Remedies, Nappy (Diaper) Rash Treatments, NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT, Paediatric Cough, Cold and Allergy Remedies, Paediatric Digestive Remedies, Paediatric Medicated Skin Care, Pharyngeal Preparations, Standard Eye Care, Sticking Plasters/Adhesive Bandages, Systemic Analgesics, Topical Allergy Remedies/Antihistamines, Topical Analgesics/Anaesthetic, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Medicated Skin Care market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
MEDICATED SKIN CARE IN ISRAEL

Euromonitor International
February 2012

LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
  Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  Table 3 Medicated Skin Care Company Shares by Value 2007-2011
  Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
  Table 5 Hair Loss Treatments Brand Shares by Value 2008-2011
  Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Chemipal Ltd in Consumer Health (israel)
Strategic Direction
Key Facts
  Summary 1 Chemipal Ltd: Key Facts
  Summary 2 Chemipal Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 3 Chemipal Ltd: Competitive Position 2011
Rekah Pharmaceutical Products Ltd in Consumer Health (israel)
Strategic Direction
Key Facts
  Summary 4 Rekah Pharmaceutical Industries Ltd: Key Facts
  Summary 5 Rekah Pharmaceutical Products Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 6 Rekah Pharmaceutical Products Ltd: Competitive Position 2011
  Summary 7 Vitamed Pharmaceutical Industries Ltd: Competitive Position 2011
Teva Pharmaceutical Industries Ltd in Consumer Health (israel)
Strategic Direction
Key Facts
  Summary 8 Teva Pharmaceutical Industries Ltd: Key Facts
  Summary 9 Teva Pharmaceutical Industries Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 10 Teva Pharmaceutical Industries Ltd: Competitive Position 2011
Executive Summary
Slower Growth for Consumer Health in 2011
the Government Becomes More Proactive in Public Health Issues
New Key Product Categories Increase Competition and Push Prices Down
the Popularity of Vds Products Boosts Sales of Healthfood Shops
Slower Growth Forecast for the Consumer Health Market
Key Trends and Developments
the Government Becomes More Proactive in Public Health Issues
New Type of Product Enters the Vds Market
Key New Product Categories Increase Competition, Pushing Prices Down
Market Segmentation Leads To More Female-specific Products in Vds
A Period of Social Unrest in 2011 Leads To Greater Consumer Price Sensitivity
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  Table 9 Life Expectancy at Birth 2006-2011
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2006-2011
  Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
  Table 12 Consumer Health Company Shares 2007-2011
  Table 13 Consumer Health Brand Shares 2008-2011
  Table 14 Penetration of Private Label by Category 2006-2011
  Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  Table 17 Forecast Sales of Consumer Health by Category: Value 2011-2016
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
  Summary 11 OTC -Switches 2009-2011
Definitions
Sources
  Summary 12 Research Sources


More Publications